...
search icon
nuvb-img

Nuvation Bio Inc Share Price

NUVB
NYQ
$5.7
+$0.08
(1.42%)
1D
Industry: Biotechnology Sector: Health Care

Nuvation Bio Inc Analyst Forecast

Nuvation Bio Inc Share Price Chart

Nuvation Bio Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.93B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.34M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.53
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.54 L
$9.75 H
$5.7

About Nuvation Bio Inc, Common Stock

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Nuvation Bio Inc Stock Returns

Time FrameNUVBSectorS&P500
1-Week Return8.78%0.06%-2.06%
1-Month Return-32.86%-2.06%-2.06%
3-Month Return13.55%6.1%1.11%
6-Month Return142.55%18.64%7.13%
1-Year Return136.51%5.25%11.74%
3-Year Return150%17.35%65.43%
5-Year Return-45.35%33.7%73.53%
10-Year Return-43%143.77%266.66%

Nuvation Bio Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue----7.87M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue103.00K368.00K484.00K222.00K7.08M[{"date":"2020-12-31","value":1.46,"profit":true},{"date":"2021-12-31","value":5.2,"profit":true},{"date":"2022-12-31","value":6.84,"profit":true},{"date":"2023-12-31","value":3.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(103.00K)(368.00K)(484.00K)(222.00K)795.00K[{"date":"2020-12-31","value":-12.96,"profit":false},{"date":"2021-12-31","value":-46.29,"profit":false},{"date":"2022-12-31","value":-60.88,"profit":false},{"date":"2023-12-31","value":-27.92,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin----10.10%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses43.45M93.32M119.73M99.82M593.42M[{"date":"2020-12-31","value":7.32,"profit":true},{"date":"2021-12-31","value":15.73,"profit":true},{"date":"2022-12-31","value":20.18,"profit":true},{"date":"2023-12-31","value":16.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(43.55M)(93.32M)(119.73M)(99.82M)(592.63M)[{"date":"2020-12-31","value":-4355100000,"profit":false},{"date":"2021-12-31","value":-9331800000,"profit":false},{"date":"2022-12-31","value":-11973400000,"profit":false},{"date":"2023-12-31","value":-9982200000,"profit":false},{"date":"2024-12-31","value":-59262700000,"profit":false}]
Total Non-Operating Income/Expense3.84M9.43M22.98M48.63M51.41M[{"date":"2020-12-31","value":7.46,"profit":true},{"date":"2021-12-31","value":18.35,"profit":true},{"date":"2022-12-31","value":44.71,"profit":true},{"date":"2023-12-31","value":94.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(41.66M)(86.85M)(104.20M)(75.80M)(567.94M)[{"date":"2020-12-31","value":-4165900000,"profit":false},{"date":"2021-12-31","value":-8684800000,"profit":false},{"date":"2022-12-31","value":-10419900000,"profit":false},{"date":"2023-12-31","value":-7580200000,"profit":false},{"date":"2024-12-31","value":-56793900000,"profit":false}]
Income Taxes(2.16M)(7.11M)(15.54M)--[{"date":"2020-12-31","value":-216300000,"profit":false},{"date":"2021-12-31","value":-711400000,"profit":false},{"date":"2022-12-31","value":-1553500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(39.50M)(79.73M)(88.66M)--[{"date":"2020-12-31","value":-3949600000,"profit":false},{"date":"2021-12-31","value":-7973400000,"profit":false},{"date":"2022-12-31","value":-8866400000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(41.66M)(86.85M)(104.20M)(75.80M)(567.94M)[{"date":"2020-12-31","value":-4165900000,"profit":false},{"date":"2021-12-31","value":-8684800000,"profit":false},{"date":"2022-12-31","value":-10419900000,"profit":false},{"date":"2023-12-31","value":-7580200000,"profit":false},{"date":"2024-12-31","value":-56793900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(41.66M)(86.85M)(104.20M)(75.80M)(567.94M)[{"date":"2020-12-31","value":-4165900000,"profit":false},{"date":"2021-12-31","value":-8684800000,"profit":false},{"date":"2022-12-31","value":-10419900000,"profit":false},{"date":"2023-12-31","value":-7580200000,"profit":false},{"date":"2024-12-31","value":-56793900000,"profit":false}]
EPS (Diluted)(0.08)(0.44)(0.48)(0.34)(0.49)[{"date":"2020-12-31","value":-8,"profit":false},{"date":"2021-12-31","value":-44,"profit":false},{"date":"2022-12-31","value":-48,"profit":false},{"date":"2023-12-31","value":-34,"profit":false},{"date":"2024-12-31","value":-48.65,"profit":false}]

Nuvation Bio Inc Ratios

Nuvation Bio Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NUVB
Cash Ratio 8.06
Current Ratio 8.48
Quick Ratio 8.39

Nuvation Bio Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NUVB
ROA (LTM) -24.82%
ROE (LTM) -52.49%

Nuvation Bio Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NUVB
Debt Ratio Lower is generally better. Negative is bad. 0.46
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.54

Nuvation Bio Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NUVB
Trailing PE NM
Forward PE NM
P/S (TTM) 72.03
P/B 6.16
Price/FCF NM
EV/R 56.73
EV/Ebitda 2.23

FAQs

What is Nuvation Bio Inc share price today?

Nuvation Bio Inc (NUVB) share price today is $5.7

Can Indians buy Nuvation Bio Inc shares?

Yes, Indians can buy shares of Nuvation Bio Inc (NUVB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NUVB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Nuvation Bio Inc be purchased?

Yes, you can purchase fractional shares of Nuvation Bio Inc (NUVB) via the Vested app. You can start investing in Nuvation Bio Inc (NUVB) with a minimum investment of $1.

How to invest in Nuvation Bio Inc shares from India?

You can invest in shares of Nuvation Bio Inc (NUVB) via Vested in three simple steps:

  • Click on Sign Up or Invest in NUVB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Nuvation Bio Inc shares
What is Nuvation Bio Inc 52-week high and low stock price?

The 52-week high price of Nuvation Bio Inc (NUVB) is $9.75. The 52-week low price of Nuvation Bio Inc (NUVB) is $1.54.

What is Nuvation Bio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Nuvation Bio Inc (NUVB) is

What is Nuvation Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Nuvation Bio Inc (NUVB) is 6.16

What is Nuvation Bio Inc dividend yield?

The dividend yield of Nuvation Bio Inc (NUVB) is 0.00%

What is the Market Cap of Nuvation Bio Inc?

The market capitalization of Nuvation Bio Inc (NUVB) is $1.93B

What is Nuvation Bio Inc's stock symbol?

The stock symbol (or ticker) of Nuvation Bio Inc is NUVB

How Can Investors Use Nuvation Bio Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Nuvation Bio Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Nuvation Bio Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Nuvation Bio Inc shares for Indian investors?

When investing in Nuvation Bio Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Nuvation Bio Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Nuvation Bio Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Nuvation Bio Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Nuvation Bio Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top